)
Pulmatrix (PULM) investor relations material
Pulmatrix Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Focuses on developing novel inhaled therapeutics for migraine and respiratory diseases using proprietary iSPERSE™ dry powder technology.
Product pipeline targets CNS disorders, COPD, and ABPA, aiming to improve drug delivery and patient outcomes.
Operates as a virtual company, incorporated in Delaware in 2013, with no physical office space.
Financial performance and metrics
As of May 27, 2026, 3,652,285 shares of common stock were issued and outstanding.
The offering could represent up to 13% dilution of current outstanding shares.
Use of proceeds and capital allocation
Will not receive proceeds from the resale of shares by the selling stockholder; all proceeds go to the selling stockholder.
Will bear all registration-related costs and expenses.
- Cullgen and Pulmatrix merge to form a Nasdaq-listed biotech with $65M cash and advanced pipeline.PULM
M&A Announcement9 Jul 2026 - Registering 490,910 shares for resale may dilute current holders by 13%, with no proceeds to the company.PULM
Registration filing4 Jun 2026 - Merger with Eos SENOLYTIX is critical as Q1 net loss narrows and cash reserves remain limited.PULM
Q1 202615 May 2026 - Revenue fell to nil in 2025 as the company pivots to merger and asset monetization strategies.PULM
Q4 202526 Feb 2026 - Virtual meeting to elect directors, ratify auditor, and review governance and executive pay.PULM
Proxy Filing2 Dec 2025 - Q2 net loss narrowed, revenue fell to zero, and future depends on Cullgen merger approval.PULM
Q2 202517 Oct 2025 - Q3 revenue and losses fell, MannKind deal cut costs, and cash runway may last into Q4 2026.PULM
Q3 202417 Oct 2025 - Q3 2025 saw zero revenue, lower expenses, and a pending Cullgen merger with cash preservation focus.PULM
Q3 202516 Oct 2025 - Net loss widened on asset write-down as cost cuts and MannKind deal extended cash runway.PULM
Q2 202413 Jun 2025
Next Pulmatrix earnings date
Next Pulmatrix earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)